Receptos (RCPT) Misses Q2 EPS by 19c

Receptos (NASDAQ: RCPT) reported Q2 EPS of ($1.04), $0.19 worse than the analyst estimate of ($0.85). Revenue for the quarter came in at $1.1 million versus the consensus estimate of $1.28 million.

For earnings history and earnings-related data on Receptos (RCPT) click here.

You May Also Be Interested In

• Okta upgraded as AI security opportunity boosts outlook
• NeOnc Phase 2a brain cancer trial shows 48.9% survival vs. 20% benchmark
• Goldman Sachs expects July core PCE to rise 0.23%